GO:1902679 negative regulation of RNA biosynthetic process: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902679 describes any process that stops, prevents, or reduces the frequency, rate, or extent of RNA biosynthetic process.
• It operates at multiple levels, including RNA polymerase III transcription, RNA stability, and translation inhibition [1,4].
• Key regulators include Maf1, TRIM21, RBM4, HNRNPA2B1, and bacterial proteins such as Rcs and EhuR [1,2,3,4,5,7].
• Dysregulation of this process is linked to viral infection, cancer, and neurological disorders [1,2,7].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of these regulatory mechanisms [1,2,7].
• Studying GO:1902679 requires integrated approaches such as RNA-seq, Ribo-seq, and proteomics [1,2,7].
Description
The Gene Ontology term GO:1902679, negative regulation of RNA biosynthetic process, encompasses any biological process that stops, prevents, or reduces the frequency, rate, or extent of RNA biosynthesis. This regulation is fundamental to cellular homeostasis, allowing organisms to rapidly adjust gene expression in response to stress, viral infection, or developmental cues [1,4]. Researchers study this term to understand how cells throttle RNA production at the transcriptional and post-transcriptional levels, a critical layer of control that impacts diverse fields from microbiology to neurobiology [1,2,3,7]. The importance of GO:1902679 extends to human health, as its dysregulation contributes to viral pathogenesis, cancer progression, and neurodegenerative conditions [1,2,7]. For example, TRIM21-mediated inhibition of RNA translation upon viral infection highlights how negative regulation of RNA biosynthetic process serves as an antiviral defense mechanism. Similarly, the RNA-binding protein RBM4 posttranscriptionally regulates human endogenous retroviruses, linking this GO term to genome stability. Understanding the molecular players and pathways that execute negative regulation of RNA biosynthetic process is therefore essential for developing targeted therapeutic interventions [1,2,7].
negative regulation of RNA biosynthetic process At A Glance
| GO ID | GO:1902679 |
|---|---|
| GO term | negative regulation of RNA biosynthetic process |
| Ontology | biological_process |
| Synonym | inhibition of RNA biosynthesis; downregulation of RNA synthesis; negative regulation of RNA formation |
| Major function | Stops, prevents, or reduces the frequency, rate, or extent of RNA biosynthetic process |
| Related processes | Regulation of transcription, RNA stability, translation inhibition |
| Key regulators | Maf1, TRIM21, RBM4, HNRNPA2B1, Rcs cascade, EhuR |
| Disease relevance | Viral infection, cancer, neurodegeneration |
What Is GO:1902679?
According to the Gene Ontology, GO:1902679 is defined as any process that stops, prevents or reduces the frequency, rate or extent of RNA biosynthetic process. In other words, it is the negative regulation of the cellular reactions that produce RNA molecules, including transcription and related biosynthetic steps [1,4].
Why Is negative regulation of RNA biosynthetic process Important in Cell Biology?
Negative regulation of RNA biosynthetic process is critical for maintaining cellular homeostasis and responding to environmental changes [1,4]. It allows cells to conserve energy by shutting down RNA production when nutrients are scarce or during stress, and it serves as a defense mechanism against viral replication [1,4]. In bacteria, this regulation controls metabolic pathways and virulence [3,5,6]. In humans, precise control of RNA biosynthesis is essential for normal development and its dysregulation is implicated in diseases such as cancer and neurodegeneration [1,2,7].
• Controls gene expression at the transcriptional and post-transcriptional levels [1,4].
• Conserves cellular resources during stress or nutrient limitation.
• Acts as an antiviral defense by inhibiting viral RNA synthesis.
• Regulates human endogenous retroviruses and genome stability.
• Modulates neuronal RNA abundance and transport.
• Influences bacterial metabolism and virulence [3,5,6].
• Dysregulation is linked to cancer and neurological disorders [1,2,7].
• Provides targets for therapeutic intervention in infectious diseases.
• Essential for developmental timing and cell fate decisions.
• Key to understanding RNA polymerase III transcription regulation.
What Happens During negative regulation of RNA biosynthetic process?
Initiation of negative regulation
In simple terms: The cell senses a signal to stop making RNA.
Negative regulation of RNA biosynthetic process begins when cellular sensors detect stress, viral infection, or nutrient deprivation [1,4]. For example, upon virus infection, TRIM21 is activated and initiates a cascade that inhibits RNA translation. In yeast, Maf1 is dephosphorylated and enters the nucleus to repress RNA polymerase III transcription when nutrients are limited. These initial events set the stage for downstream repression of RNA biosynthesis [1,4].
Repression of RNA polymerase activity
In simple terms: The enzymes that make RNA are turned down or off.
A central mechanism is the direct inhibition of RNA polymerases. Maf1 binds to RNA polymerase III and prevents its recruitment to target genes, thereby reducing tRNA and 5S rRNA synthesis. In bacteria, the Rcs regulatory cascade can repress genes involved in RNA biosynthesis. Similarly, the EhuR protein negatively regulates ectoine uptake and catabolism, indirectly affecting RNA synthesis.
Post-transcriptional and translational inhibition
In simple terms: Even if RNA is made, its use can be blocked.
Negative regulation can also occur after RNA is synthesized. TRIM21 promotes the degradation of viral RNA or inhibits its translation. RBM4 regulates human endogenous retroviruses posttranscriptionally, reducing their RNA levels. HNRNPA2B1 regulates neurite RNA abundance and motor-dependent cargo transport, affecting the availability of RNA for translation. These mechanisms ensure that RNA biosynthetic process is effectively dampened [1,2,7].
Feedforward loops and sRNA-driven control
In simple terms: Small RNAs can amplify the shutdown of RNA production.
In bacteria, small RNAs (sRNAs) can create feedforward loops that reinforce negative regulation. For instance, in Staphylococcus aureus, an sRNA-driven feedforward loop controls aconitase expression during iron deficiency, impacting RNA biosynthesis. This layered regulation ensures robust repression of RNA biosynthetic process under specific conditions.
Key Genes Involved in GO:1902679 negative regulation of RNA biosynthetic process
The following genes and proteins are key players in negative regulation of RNA biosynthetic process, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TRIM21 | Inhibits RNA translation upon viral infection | Antiviral defense, autoimmune diseases |
| RBM4 | Posttranscriptional regulation of endogenous retroviruses | Genome stability, cancer |
| Maf1 | Represses RNA polymerase III transcription | Nutrient sensing, cancer metabolism |
| HNRNPA2B1 | Regulates neurite RNA abundance and transport | Neurodegeneration, RNA trafficking |
| Rcs cascade | Complex regulatory cascade in bacteria | Bacterial virulence, biofilm formation |
| EhuR | Negative regulator of ectoine uptake and catabolism | Bacterial stress response |
| Aconitase | Controlled by sRNA feedforward loop | Iron metabolism, bacterial pathogenesis |
| RNA polymerase III | Target of Maf1-mediated repression | Transcription regulation |
| PKR | Kinase activated by viral RNA, inhibited by TRIM21 | Innate immunity |
| eIF2α | Translation initiation factor phosphorylated by PKR | Stress response |
| Exon definition factors | Regulate alternative splicing | Viral and mammalian gene expression |
| SR proteins | Splicing regulators | RNA processing |
| hnRNP proteins | RNA-binding proteins | RNA stability and transport |
| sRNAs | Small regulatory RNAs | Bacterial gene regulation |
| RcsB | Response regulator in Rcs cascade | Bacterial signaling |
| RcsC | Sensor kinase in Rcs cascade | Bacterial signaling |
| RcsD | Phosphorelay protein in Rcs cascade | Bacterial signaling |
How Is negative regulation of RNA biosynthetic process Regulated?
Negative regulation of RNA biosynthetic process is itself tightly regulated. In yeast, Maf1 is controlled by phosphorylation status: it is phosphorylated by TOR and PKA under nutrient-rich conditions and dephosphorylated upon stress, allowing nuclear import and repression of RNA polymerase III. In mammalian cells, TRIM21 is induced by interferon and regulates PKR-dependent translation inhibition upon viral infection. RBM4 levels and activity can be modulated by cellular stress, affecting endogenous retrovirus RNA. Bacterial systems use two-component signaling cascades, such as Rcs, to sense envelope stress and repress RNA biosynthesis. Additionally, sRNA-driven feedforward loops provide fine-tuned control in response to iron deficiency.
negative regulation of RNA biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRIM21 | Viral infection, autoimmunity | Knockout mice, overexpression cell lines |
| RBM4 | Cancer, genome instability | CRISPR knockout in cancer cell lines |
| Maf1 | Cancer, metabolic disorders | Knockout yeast and mammalian cells |
| HNRNPA2B1 | Neurodegeneration (ALS) | Knock-in mice, neuronal cultures |
| Rcs cascade | Bacterial virulence | Bacterial knockout strains |
Viral infection and innate immunity
Negative regulation of RNA biosynthetic process is a critical antiviral mechanism. TRIM21 inhibits PKR-dependent RNA translation upon virus infection, limiting viral replication. Dysregulation of this pathway can lead to increased susceptibility to viral infections or autoimmune responses.
Cancer
Altered RNA biosynthesis is a hallmark of cancer. Maf1, a negative regulator of RNA polymerase III, is often downregulated in cancer, leading to increased RNA synthesis and cell proliferation. RBM4, which posttranscriptionally regulates endogenous retroviruses, may also influence cancer progression through genome stability.
Neurodegeneration
HNRNPA2B1 regulates neurite RNA abundance and motor-dependent cargo transport, and its dysfunction is linked to neurodegenerative diseases such as amyotrophic lateral sclerosis. Negative regulation of RNA biosynthetic process in neurons is essential for maintaining proper RNA homeostasis.
Bacterial pathogenesis
In bacteria, negative regulation of RNA biosynthetic process controls virulence factor expression. The Rcs cascade represses genes involved in capsule synthesis and biofilm formation, impacting pathogenicity. EhuR regulates ectoine uptake, affecting stress survival.
From negative regulation of RNA biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TRIM21 inhibit viral RNA translation? | TRIM21 knockout cell lines |
| How does Maf1 repress RNA polymerase III? | Maf1 point mutations in yeast |
| What is the role of RBM4 in endogenous retrovirus regulation? | RBM4 overexpression and knockout |
| How does HNRNPA2B1 affect neurite RNA transport? | Tagged knock-in in neurons |
| Does EhuR regulate ectoine catabolism? | EhuR knockout in Sinorhizobium meliloti |
| How does sRNA feedforward loop control aconitase? | sRNA knockout in Staphylococcus aureus |
How to Study the negative regulation of RNA biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | RNA abundance and splicing | Global effects of negative regulators [1,4] |
| Ribo-seq | Translation efficiency | TRIM21-mediated inhibition |
| Proteomics | Protein interactions and modifications | Maf1 phosphorylation |
| Imaging | RNA localization | HNRNPA2B1 in neurites |
| ChIP-seq | DNA binding of transcription factors | RNA polymerase III occupancy |
| CRISPR screens | Gene function | Identify novel regulators [1,2] |
| Northern blot | Specific RNA levels | Endogenous retrovirus RNA |
| Polysome profiling | mRNA translation | PKR-dependent inhibition |
RNA sequencing (RNA-seq)
RNA-seq measures global RNA levels and can identify changes in RNA biosynthetic process upon negative regulation. It is used to quantify transcripts affected by regulators like Maf1 or TRIM21 [1,4].
Ribosome profiling (Ribo-seq)
Ribo-seq captures translating ribosomes, allowing researchers to assess translation inhibition, such as that mediated by TRIM21 upon viral infection.
Proteomics
Mass spectrometry-based proteomics identifies protein interactions and post-translational modifications of key regulators like Maf1 and HNRNPA2B1 [4,7].
Imaging
Fluorescence microscopy visualizes RNA localization and transport, as shown for HNRNPA2B1 in neurites.
How CRISPR Can Be Used to Study GO:1902679 negative regulation of RNA biosynthetic process
Knockout
CRISPR knockout of genes like TRIM21, RBM4, or Maf1 allows researchers to study loss of negative regulation of RNA biosynthetic process. For example, TRIM21 knockout cells show increased viral RNA translation.
Point Mutation
Introducing point mutations in catalytic or regulatory domains of Maf1 or HNRNPA2B1 can dissect their roles in RNA biosynthesis repression [4,7].
Knock-in
Tagged knock-in of HNRNPA2B1 with fluorescent proteins enables live imaging of RNA transport in neurons.
Overexpression
Overexpression of RBM4 or TRIM21 can enhance negative regulation of RNA biosynthetic process, providing gain-of-function models [1,2].
How EDITGENE Supports negative regulation of RNA biosynthetic process Research
Researchers studying negative regulation of RNA biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in repressing RNA biosynthesis. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling functional validation of these regulators.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of RNA biosynthetic process research.
Frequently Asked Questions About negative regulation of RNA biosynthetic process
What is GO:1902679?
GO:1902679 is the Gene Ontology term for negative regulation of RNA biosynthetic process, defined as any process that stops, prevents or reduces the frequency, rate or extent of RNA biosynthetic process.
What genes are involved in negative regulation of RNA biosynthetic process?
Key genes include TRIM21, RBM4, Maf1, HNRNPA2B1, and bacterial regulators like Rcs and EhuR [1,2,3,4,5,7].
How does Maf1 regulate RNA biosynthesis?
Maf1 represses RNA polymerase III transcription by binding to the polymerase and preventing its recruitment to target genes.
What is the role of TRIM21 in RNA regulation?
TRIM21 inhibits PKR-dependent RNA translation upon viral infection, acting as a negative regulator of RNA biosynthetic process.
How is negative regulation of RNA biosynthetic process studied?
Common methods include RNA-seq, Ribo-seq, proteomics, imaging, and CRISPR screens [1,2,4,7].
What diseases are associated with dysregulation of this process?
Dysregulation is linked to viral infections, cancer, neurodegeneration, and bacterial pathogenesis [1,2,3,4,7].
Can CRISPR be used to study negative regulation of RNA biosynthetic process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect these pathways [1,2,4,7].
What is the difference between negative regulation of RNA biosynthetic process and transcription?
Negative regulation of RNA biosynthetic process is a broader term that includes inhibition of transcription as well as post-transcriptional and translational mechanisms that reduce RNA synthesis [1,4].
Which RNA polymerases are targeted by negative regulation?
RNA polymerase III is a major target, as shown by Maf1-mediated repression.
How does RBM4 regulate endogenous retroviruses?
RBM4 posttranscriptionally regulates human endogenous retroviruses, reducing their RNA levels.
Conclusion
Negative regulation of RNA biosynthetic process (GO:1902679) is a fundamental biological process that controls RNA production at multiple levels, from transcription to translation. Its dysregulation is implicated in viral infections, cancer, and neurodegeneration, making it a critical area of research. By leveraging CRISPR-based models and advanced omics technologies, researchers can uncover the precise mechanisms and identify therapeutic targets. EDITGENE offers comprehensive services to support these studies, from knockout cell lines to bioinformatics analysis.
References
- 1. Li H et al.. 2023. Regulation of PKR-dependent RNA translation inhibition by TRIM21 upon virus infection or other stress.. PLoS Pathog 19(6):e1011443 PMID: 37327222
- 2. Foroushani AK et al.. 2020. Posttranscriptional regulation of human endogenous retroviruses by RNA-binding motif protein 4, RBM4.. Proc Natl Acad Sci U S A 117(42):26520-26530 PMID: 33020268
- 3. Wall E et al.. 2018. The Complex Rcs Regulatory Cascade.. Annu Rev Microbiol 72:111-139 PMID: 29897834
- 4. Cieśla M et al.. 2008. Regulation of RNA polymerase III transcription by Maf1 protein.. Acta Biochim Pol 55(2):215-25 PMID: 18560610
- 5. Yu Q et al.. 2017. Negative Regulation of Ectoine Uptake and Catabolism in Sinorhizobium meliloti: Characterization of the EhuR Gene.. J Bacteriol 199(1) PMID: 27795315
- 6. Barrault M et al.. 2024. Staphylococcal aconitase expression during iron deficiency is controlled by an sRNA-driven feedforward loop and moonlighting activity.. Nucleic Acids Res 52(14):8241-8253 PMID: 38869061
- 7. Lo J et al.. 2025. The RNA-binding protein HNRNPA2B1 regulates neurite RNA abundance and motor-dependent cargo transport.. Mol Biol Cell 36(12):ar152 PMID: 41191559
- 8. Zheng ZM. 2004. Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression.. J Biomed Sci 11(3):278-94 PMID: 15067211
